1-12 of 12
trimethylamine
Close
Sort by
Journal Articles

Transplant-associated thrombotic microangiopathy in pediatric patients: pre-HSCT risk stratification and prophylaxis

Christine S. Higham, Griffin Collins, Kristin A. Shimano, Alexis Melton, Sandhya Kharbanda, Lena E. Winestone, James N. Huang, Jasmeen Dara, Janel R. Long-Boyle, Christopher C. Dvorak
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2106–2114.
https://doi.org/10.1182/bloodadvances.2020003988
Published: 2021
Includes: Supplemental data
Journal Articles

Risk factors and appropriate therapeutic strategies for thrombotic microangiopathy after allogeneic HSCT

Hiroyuki Matsui, Yasuyuki Arai, Hiroharu Imoto, Takaya Mitsuyoshi, Naoki Tamura, Tadakazu Kondo, Junya Kanda, Takayuki Ishikawa, Kazunori Imada, Yasunori Ueda, Yusuke Toda, Naoyuki Anzai, Kazuhiro Yago, Masaharu Nohgawa, Akihito Yonezawa, Hiroko Tsunemine, Mitsuru Itoh, Kazuyo Yamamoto, Masaaki Tsuji, Toshinori Moriguchi, Akifumi Takaori-Kondo, Kyoto Stem Cell Transplantation Group (KSCTG)
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3169–3179.
https://doi.org/10.1182/bloodadvances.2020002007
Published: 2020
Includes: Supplemental data
Journal Articles

Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort

Clinical Trials & Observations
Michelle Schoettler, Leslie E. Lehmann, Steven Margossian, Maia Lee, Leslie S. Kean, Pei-Chi Kao, Clement Ma, Christine N. Duncan
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2536–2547.
https://doi.org/10.1182/bloodadvances.2019001242
Published: 2020
Includes: Supplemental data
Journal Articles

New insights into risk factors for transplant-associated thrombotic microangiopathy in pediatric HSCT

Clinical Trials & Observations
Reem Elfeky, Giovanna Lucchini, Su-Han Lum, Giorgio Ottaviano, Natalia Builes, Zohreh Nademi, Alexandra Battersby, Terence Flood, Stephen Owens, Andrew J. Cant, Helen Young, Sinéad Greener, Patrick Walsh, David Kavanagh, Srinivas Annavarapu, Kanchan Rao, Persis Amrolia, Robert Chiesa, Austen Worth, Claire Booth, Roderick Skinner, Bilyana Doncheva, Joseph Standing, Andrew R. Gennery, Waseem Qasim, Mary Slatter, Paul Veys
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2418–2429.
https://doi.org/10.1182/bloodadvances.2019001315
Published: 2020
Includes: Supplemental data
Journal Articles

Interferon-complement loop in transplant-associated thrombotic microangiopathy

Clinical Trials & Observations
Sonata Jodele, Mario Medvedovic, Nathan Luebbering, Jenny Chen, Christopher E. Dandoy, Benjamin L. Laskin, Stella M. Davies
Journal: Blood Advances
Blood Adv (2020) 4 (6): 1166–1177.
https://doi.org/10.1182/bloodadvances.2020001515
Published: 2020
Includes: Supplemental data
Journal Articles

TA-TMA: state of the art for diagnosis and treatment

Clinical Trials & Observations
Christopher C. Dvorak
Journal: Blood Advances
Blood Adv (2020) 4 (1): 217.
https://doi.org/10.1182/bloodadvances.2019000321
Published: 2020
Includes: Supplemental data
Journal Articles

Allogeneic reactivity–mediated endothelial cell complications after HSCT: a plea for consensual definitions

Simona Pagliuca, David Michonneau, Flore Sicre de Fontbrune, Aurélien Sutra del Galy, Aliénor Xhaard, Marie Robin, Régis Peffault de Latour, Gérard Socie
Journal: Blood Advances
Blood Adv (2019) 3 (15): 2424–2435.
https://doi.org/10.1182/bloodadvances.2019000143
Published: 2019
Journal Articles

Pathophysiology and management of monoclonal gammopathy of renal significance

Clinical Trials & Observations
Ankur Jain, Richard Haynes, Jaimal Kothari, Akhil Khera, Maria Soares, Karthik Ramasamy
Journal: Blood Advances
Blood Adv (2019) 3 (15): 2409–2423.
https://doi.org/10.1182/bloodadvances.2019031914
Published: 2019
Includes: Supplemental data
Journal Articles

A critical role of the Gas6-Mer axis in endothelial dysfunction contributing to TA-TMA associated with GVHD

Miki Furukawa, Xintao Wang, Hiroshi Ohkawara, Masahiko Fukatsu, Lobna Alkebsi, Hiroshi Takahashi, Kayo Harada-Shirado, Akiko Shichishima-Nakamura, Satoshi Kimura, Kazuei Ogawa, Takayuki Ikezoe
Journal: Blood Advances
Blood Adv (2019) 3 (14): 2128–2143.
https://doi.org/10.1182/bloodadvances.2019000222
Published: 2019
Journal Articles

Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHD

Clinical Trials & Observations
Sarah A. Wall, Qiuhong Zhao, Martha Yearsley, Luke Blower, Akwasi Agyeman, Parvathi Ranganathan, Shangbin Yang, Haiwa Wu, Matthew Bostic, Samantha Jaglowski, Jonathan E. Brammer, Basem William, Hannah Choe, Alice S. Mims, Sam Penza, Yvonne Efebera, Steven Devine, Spero Cataland, Stella M. Davies, Sumithira Vasu
Journal: Blood Advances
Blood Adv (2018) 2 (20): 2619–2628.
https://doi.org/10.1182/bloodadvances.2018020321
Published: 2018
Includes: Supplemental data
Journal Articles

Complement-mediated thrombotic microangiopathy associated with lupus nephritis

Mi Hee Park, Nicholas Caselman, Scott Ulmer, Ilene Ceil Weitz
Journal: Blood Advances
Blood Adv (2018) 2 (16): 2090–2094.
https://doi.org/10.1182/bloodadvances.2018019596
Published: 2018
Journal Articles

Use of the complement inhibitor Coversin to treat HSCT-associated TMA

Clinical Trials & Observations
Timothy H. J. Goodship, Fernando Pinto, Wynn H. Weston-Davies, Juliana Silva, Jun-ichi Nishimura, Miles A. Nunn, Ian Mackie, Samuel J. Machin, Liina Palm, Jeremy W. Pryce, Robert Chiesa, Persis Amrolia, Paul Veys
Journal: Blood Advances
Blood Adv (2017) 1 (16): 1254–1258.
https://doi.org/10.1182/bloodadvances.2016002832
Published: 2017
Includes: Supplemental data